GSK Forms Joint Venture With Shenzhen Neptunus Interlong Bio-Technique For Flu Vaccine

25 Nov 2008

• By PharmAsia News

HONG KONG - GlaxoSmithKline announced Nov. 21 a joint venture with Shenzhen Neptunus Interlong Bio-Technique to develop flu vaccines aimed at strains specific to China, Hong Kong and Macau

GSK Forms Joint Venture With Shenzhen Neptunus Interlong Bio-Technique For Flu Vaccine

More from Archive

More from Scrip